US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

56.63

+0.13000.23%

Post-market: 57.050.4200+0.74%17:16 EDT

Volume:1.88M

Turnover:106.50M

Market Cap:10.83B

PE:-13.83

High:57.49

Open:56.63

Low:55.71

Close:56.50

52wk High:57.49

52wk Low:21.72

Shares:191.17M

Float Shares:151.20M

Volume Ratio:0.76

T/O Rate:1.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.0935

EPS(LYR):-2.8793

ROE:-1789.67%

ROA:-41.96%

PB:-6.06

PE(LYR):-19.67

Loading ...

Overview Company News Filings

Jefferies Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)

Frank McCormick, Director, Reports Disposal of Common Shares of BridgeBio Pharma Inc

BridgeBio Pharma Inc. Publishes Document on Infigratinib's Preclinical Improvement in Crouzon/Pfeiffer Syndromes

BRIEF-Bridgebio Pharma Says Intends To Initiate Registrational Clinical Study Of Encaleret In 2026

BridgeBio Pharma - Intends to Initiate Registrational Clinical Study of Encaleret in 2026

THOMSON REUTERS

BridgeBio Pharma Inc - Phase 2 Study Evaluated Encaleret's Effects on Calcium Handling

THOMSON REUTERS

BridgeBio Pharma Inc - Encaleret Was Well-Tolerated With No Serious Adverse Events Reported Over Study Period

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum

BUZZ-US FDA program favorable for rare disease drug developers, says Jefferies

BridgeBio Pharma Is Maintained at Overweight by JP Morgan

BridgeBio Pharma to Host Investor Webinar on Phase 3 Trial for Encaleret in Treating Autosomal Dominant Hypocalcemia Type 1

BridgeBio Pharma Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

U.S. RESEARCH ROUNDUP-BOK Financial, Sable Offshore, Zscaler

BridgeBio Pharma to Present Promising Phase 2 Data for Encaleret in Treating Post-Surgical Hypoparathyroidism at ASBMR Annual Meeting 2025

Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (Cvm) Through Month 42 of the Attribute-Cm Open Label Extension

THOMSON REUTERS

BridgeBio Pharma Is Maintained at Buy by HC Wainwright & Co.

BridgeBio Pharma, Inc. : H.c. Wainwright Raises Target Price to $70 From $56

THOMSON REUTERS

BridgeBio Pharma Inc. Releases Document on Acoramidis for Transthyretin Amyloid Cardiomyopathy Treatment

BridgeBio Pharma Inc. to Participate in Morgan Stanley Global Healthcare Conference

BridgeBio Pharma to Present New Findings from ATTRibute-CM Study on Acoramidis at ESC Congress 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBIO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBIO\",,,,,undefined,":{"symbol":"BBIO","market":"US","secType":"STK","nameCN":"BridgeBio Pharma, Inc.","latestPrice":56.63,"timestamp":1760558400000,"preClose":56.5,"halted":0,"volume":1880914,"hourTrading":{"tag":"盘后","latestPrice":57.05,"preClose":56.63,"latestTime":"17:16 EDT","volume":344720,"amount":19521386.7368,"timestamp":1760562972149},"delay":0,"floatShares":151204231,"shares":191168504,"eps":-4.093525,"marketStatus":"Post-Mkt","change":0.13,"latestTime":"10-15 18:18:36 EDT","open":56.63,"high":57.49,"low":55.71,"amount":106496250.34530999,"amplitude":0.031504,"askPrice":60,"askSize":10,"bidPrice":57,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-4.093525,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1760572800000},"marketStatusCode":4,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":56.5,"preHourTrading":{"tag":"盘前","latestPrice":56.5,"preClose":56.5,"latestTime":"09:29 EDT","volume":16422,"amount":925745.647848,"timestamp":1760534949254},"postHourTrading":{"tag":"盘后","latestPrice":57.05,"preClose":56.63,"latestTime":"17:16 EDT","volume":344720,"amount":19521386.7368,"timestamp":1760562972149},"volumeRatio":0.7601,"impliedVol":0.7501,"impliedVolPercentile":0.812},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBIO\",,,,,undefined,":{"symbol":"BBIO","floatShares":151204231,"roa":"-41.96%","roe":"-1789.67%","lyrEps":-2.879266,"volumeRatio":0.7601,"shares":191168504,"dividePrice":0,"high":57.49,"amplitude":0.031504,"preClose":56.5,"low":55.71,"week52Low":21.72,"pbRate":"-6.06","psRate":"45.91","week52High":57.49,"institutionHeld":0,"latestPrice":56.63,"committee":-0.666667,"eps":-4.093525,"divideRate":0,"volume":1880914,"delay":0,"ttmEps":-4.093525,"open":56.63,"prevYearClose":27.44,"prevWeekClose":55.49,"prevMonthClose":51.94,"prevQuarterClose":51.94,"fiveDayClose":55.3,"twentyDayClose":51.18,"sixtyDayClose":45.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-05","symbol":"BBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-04-29","symbol":"BBIO","fiscalQuarterEnding":"2025/03","expectedEps":1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-02-20","symbol":"BBIO","fiscalQuarterEnding":"2024/12","expectedEps":-1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2024-11-12","symbol":"BBIO","fiscalQuarterEnding":"2024/09","expectedEps":-1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2024-08-01","symbol":"BBIO","fiscalQuarterEnding":"2024/06","expectedEps":-1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":-1.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2778,"buy":0.7222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7222,"analysts":18,"updateTime":1753156800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBIO","date":"2025-10-14","current":-13.834043,"percent":0.219334,"low":-24.533016,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"high":-1.291392,"avg":-9.801269,"sd":5.433319,"marketCap":10697789483},"quantilePoints":[{"date":"2020-10-16","current":-14.496805,"twenty":-18.927326,"median":-14.219284,"eighty":-11.942526,"marketCap":5020562537},{"date":"2020-10-23","current":-14.033275,"twenty":-18.889011,"median":-14.123676,"eighty":-11.947309,"marketCap":4860031980},{"date":"2020-10-30","current":-13.580361,"twenty":-18.883538,"median":-14.058044,"eighty":-11.956547,"marketCap":4703177695},{"date":"2020-11-06","current":-11.999283,"twenty":-18.878064,"median":-14.054742,"eighty":-11.995815,"marketCap":4826123505},{"date":"2020-11-13","current":-13.262445,"twenty":-18.828803,"median":-14.033275,"eighty":-11.999283,"marketCap":5334168760},{"date":"2020-11-20","current":-13.478813,"twenty":-18.82333,"median":-13.991375,"eighty":-12.026486,"marketCap":5421192193},{"date":"2020-11-27","current":-14.972057,"twenty":-18.766405,"median":-14.022925,"eighty":-12.033153,"marketCap":6021776452},{"date":"2020-12-04","current":-15.904573,"twenty":-18.743416,"median":-14.051439,"eighty":-12.074825,"marketCap":6396835193},{"date":"2020-12-11","current":-18.696025,"twenty":-18.714954,"median":-14.088121,"eighty":-12.09832,"marketCap":7519560051},{"date":"2020-12-18","current":-19.774818,"twenty":-18.752525,"median":-14.139769,"eighty":-12.11487,"marketCap":7953451536},{"date":"2020-12-24","current":-21.179686,"twenty":-18.848507,"median":-14.160658,"eighty":-12.145667,"marketCap":8518491012},{"date":"2020-12-31","current":-21.670324,"twenty":-18.912,"median":-14.227887,"eighty":-12.164985,"marketCap":8715825839},{"date":"2021-01-08","current":-19.963759,"twenty":-19.014902,"median":-14.257579,"eighty":-12.188813,"marketCap":8029443830},{"date":"2021-01-15","current":-20.908464,"twenty":-19.101383,"median":-14.301767,"eighty":-12.227589,"marketCap":8409405299},{"date":"2021-01-22","current":-21.199057,"twenty":-19.153929,"median":-14.368324,"eighty":-12.247649,"marketCap":8526282041},{"date":"2021-01-29","current":-17.318055,"twenty":-19.153929,"median":-14.428476,"eighty":-12.309932,"marketCap":6965339215},{"date":"2021-02-05","current":-20.832925,"twenty":-19.169033,"median":-14.496805,"eighty":-12.366172,"marketCap":8379023284},{"date":"2021-02-12","current":-24.514819,"twenty":-19.240829,"median":-14.533758,"eighty":-12.38011,"marketCap":9859884665},{"date":"2021-02-19","current":-24.267341,"twenty":-19.393888,"median":-14.608054,"eighty":-12.401532,"marketCap":9760349012},{"date":"2021-02-26","current":-23.082259,"twenty":-19.68266,"median":-14.654314,"eighty":-12.426535,"marketCap":10357563680},{"date":"2021-03-05","current":-20.319442,"twenty":-19.823577,"median":-14.735677,"eighty":-12.434869,"marketCap":9117821338},{"date":"2021-03-12","current":-23.167168,"twenty":-19.963759,"median":-14.782839,"eighty":-12.472929,"marketCap":10395664509},{"date":"2021-03-19","current":-22.096005,"twenty":-20.073201,"median":-14.841966,"eighty":-12.485349,"marketCap":9915007903},{"date":"2021-03-26","current":-19.862238,"twenty":-20.115073,"median":-14.906468,"eighty":-12.491444,"marketCap":8912663031},{"date":"2021-04-01","current":-19.38544,"twenty":-20.115452,"median":-15.027333,"eighty":-12.515058,"marketCap":8698712225},{"date":"2021-04-09","current":-17.795024,"twenty":-20.106315,"median":-15.082555,"eighty":-12.565045,"marketCap":7985054399},{"date":"2021-04-16","current":-18.000766,"twenty":-20.079386,"median":-15.290504,"eighty":-12.599324,"marketCap":8077375637},{"date":"2021-04-23","current":-17.788493,"twenty":-20.044158,"median":-15.319812,"eighty":-12.605139,"marketCap":7982123566},{"date":"2021-04-30","current":-18.603351,"twenty":-20.019831,"median":-15.360367,"eighty":-12.635536,"marketCap":8347770201},{"date":"2021-05-07","current":-13.789937,"twenty":-20.010471,"median":-15.376486,"eighty":-12.643209,"marketCap":7170119357},{"date":"2021-05-14","current":-15.406372,"twenty":-19.984428,"median":-15.341143,"eighty":-12.662152,"marketCap":8010589313},{"date":"2021-05-21","current":-16.623722,"twenty":-19.966654,"median":-15.399488,"eighty":-12.666883,"marketCap":8643554253},{"date":"2021-05-28","current":-16.996966,"twenty":-19.882542,"median":-15.453641,"eighty":-12.671032,"marketCap":8837623692},{"date":"2021-06-04","current":-16.640949,"twenty":-19.853018,"median":-15.478579,"eighty":-12.685213,"marketCap":8652511304},{"date":"2021-06-11","current":-18.355001,"twenty":-19.83702,"median":-15.547805,"eighty":-12.695943,"marketCap":9543737883},{"date":"2021-06-18","current":-17.608513,"twenty":-19.826327,"median":-15.720083,"eighty":-12.70625,"marketCap":9155599004},{"date":"2021-06-25","current":-17.355855,"twenty":-19.798145,"median":-15.849241,"eighty":-12.735844,"marketCap":9024228922},{"date":"2021-07-02","current":-18.332032,"twenty":-19.777367,"median":-15.904573,"eighty":-12.761796,"marketCap":9531795148},{"date":"2021-07-09","current":-18.423908,"twenty":-19.765066,"median":-15.95692,"eighty":-12.777314,"marketCap":9579566087},{"date":"2021-07-16","current":-16.991224,"twenty":-19.723327,"median":-16.220389,"eighty":-12.794169,"marketCap":8834638009},{"date":"2021-07-23","current":-17.398922,"twenty":-19.661012,"median":-16.344741,"eighty":-12.805568,"marketCap":9046621550},{"date":"2021-07-30","current":-15.346079,"twenty":-19.606599,"median":-16.220389,"eighty":-12.814383,"marketCap":7979239634},{"date":"2021-08-06","current":-16.359477,"twenty":-19.514064,"median":-16.18189,"eighty":-12.819413,"marketCap":8102308897},{"date":"2021-08-13","current":-15.155951,"twenty":-19.413996,"median":-16.072735,"eighty":-12.846913,"marketCap":7506242549},{"date":"2021-08-20","current":-14.826343,"twenty":-19.396383,"median":-15.911433,"eighty":-12.877744,"marketCap":7342998248},{"date":"2021-08-27","current":-15.264813,"twenty":-19.390509,"median":-15.885226,"eighty":-12.87943,"marketCap":7560158098},{"date":"2021-09-03","current":-15.609541,"twenty":-19.381725,"median":-15.844422,"eighty":-12.892818,"marketCap":7730890670},{"date":"2021-09-10","current":-15.225502,"twenty":-19.362334,"median":-15.782487,"eighty":-12.91781,"marketCap":7540688594},{"date":"2021-09-17","current":-15.760738,"twenty":-19.298571,"median":-15.74041,"eighty":-12.954856,"marketCap":7805773377},{"date":"2021-09-24","current":-14.687242,"twenty":-19.261739,"median":-15.613092,"eighty":-12.963853,"marketCap":7274106157},{"date":"2021-10-01","current":-14.436255,"twenty":-19.249167,"median":-15.567921,"eighty":-12.97305,"marketCap":7149800864},{"date":"2021-10-08","current":-13.338568,"twenty":-19.240829,"median":-15.484501,"eighty":-13.008846,"marketCap":6606152411},{"date":"2021-10-15","current":-14.50883,"twenty":-19.223163,"median":-15.472285,"eighty":-13.010321,"marketCap":7185744563},{"date":"2021-10-22","current":-14.212484,"twenty":-19.209589,"median":-15.429341,"eighty":-13.026819,"marketCap":7038974458},{"date":"2021-10-29","current":-14.665221,"twenty":-19.182062,"median":-15.400607,"eighty":-13.07699,"marketCap":7263200057},{"date":"2021-11-05","current":-14.682487,"twenty":-19.169033,"median":-15.392604,"eighty":-13.110082,"marketCap":7860166663},{"date":"2021-11-12","current":-13.163935,"twenty":-19.157212,"median":-15.36702,"eighty":-13.11831,"marketCap":7047220624},{"date":"2021-11-19","current":-11.72602,"twenty":-19.156665,"median":-15.341143,"eighty":-13.026819,"marketCap":6277442766},{"date":"2021-11-26","current":-10.873719,"twenty":-19.154476,"median":-15.313196,"eighty":-12.990726,"marketCap":5821169083},{"date":"2021-12-03","current":-10.618028,"twenty":-19.151739,"median":-15.29719,"eighty":-12.909107,"marketCap":5684286978},{"date":"2021-12-10","current":-9.949934,"twenty":-19.124371,"median":-15.270861,"eighty":-12.826359,"marketCap":5326627285},{"date":"2021-12-17","current":-11.726583,"twenty":-19.118898,"median":-15.23911,"eighty":-12.790369,"marketCap":6277744216},{"date":"2021-12-23","current":-11.168436,"twenty":-19.083868,"median":-15.195263,"eighty":-12.709249,"marketCap":5978944198},{"date":"2021-12-31","current":-4.586153,"twenty":-19.070732,"median":-15.161189,"eighty":-12.671032,"marketCap":2455164678},{"date":"2022-01-07","current":-4.028006,"twenty":-19.0565,"median":-15.154439,"eighty":-12.635536,"marketCap":2156364660},{"date":"2022-01-14","current":-3.505602,"twenty":-19.048838,"median":-15.122688,"eighty":-12.515058,"marketCap":1876699619},{"date":"2022-01-21","current":-2.831977,"twenty":-19.029609,"median":-15.09041,"eighty":-12.457705,"marketCap":1516078908},{"date":"2022-01-28","current":-2.485541,"twenty":-18.9953,"median":-15.074503,"eighty":-12.370463,"marketCap":1330616828},{"date":"2022-02-04","current":-2.746742,"twenty":-18.971579,"median":-15.027333,"eighty":-12.230213,"marketCap":1470449348},{"date":"2022-02-11","current":-2.386559,"twenty":-18.96564,"median":-14.97631,"eighty":-12.111576,"marketCap":1277627662},{"date":"2022-02-18","current":-2.221589,"twenty":-18.952504,"median":-14.926132,"eighty":-12.015605,"marketCap":1189312386},{"date":"2022-02-25","current":-2.072926,"twenty":-18.937178,"median":-14.906468,"eighty":-11.951004,"marketCap":1166101778},{"date":"2022-03-04","current":-1.970592,"twenty":-18.912,"median":-14.885263,"eighty":-11.912854,"marketCap":1108534728},{"date":"2022-03-11","current":-2.251355,"twenty":-18.886822,"median":-14.87267,"eighty":-11.825033,"marketCap":1266475095},{"date":"2022-03-18","current":-2.923088,"twenty":-18.881348,"median":-14.833903,"eighty":-11.728443,"marketCap":1644351114},{"date":"2022-03-25","current":-2.71842,"twenty":-18.870701,"median":-14.801469,"eighty":-11.69159,"marketCap":1529217015},{"date":"2022-04-01","current":-2.846993,"twenty":-18.847315,"median":-14.776883,"eighty":-11.608067,"marketCap":1601544847},{"date":"2022-04-08","current":-2.870609,"twenty":-18.826614,"median":-14.735625,"eighty":-11.535084,"marketCap":1614829550},{"date":"2022-04-14","current":-2.881105,"twenty":-18.809449,"median":-14.718485,"eighty":-11.491836,"marketCap":1620733863},{"date":"2022-04-22","current":-2.629205,"twenty":-18.753576,"median":-14.690266,"eighty":-11.338723,"marketCap":1479030356},{"date":"2022-04-29","current":-2.105628,"twenty":-18.749985,"median":-14.681194,"eighty":-11.176698,"marketCap":1184497603},{"date":"2022-05-06","current":-1.660715,"twenty":-18.734659,"median":-14.654146,"eighty":-11.087543,"marketCap":989548848},{"date":"2022-05-13","current":-1.640886,"twenty":-18.706197,"median":-14.641584,"eighty":-11.009507,"marketCap":977733339},{"date":"2022-05-20","current":-1.886275,"twenty":-18.697156,"median":-14.5737,"eighty":-10.959651,"marketCap":1123950259},{"date":"2022-05-27","current":-1.794564,"twenty":-18.693024,"median":-14.524054,"eighty":-10.880079,"marketCap":1069303531},{"date":"2022-06-03","current":-1.789607,"twenty":-18.681019,"median":-14.50883,"eighty":-10.818731,"marketCap":1066349654},{"date":"2022-06-10","current":-1.650801,"twenty":-18.650314,"median":-14.476362,"eighty":-10.633999,"marketCap":983641094},{"date":"2022-06-17","current":-1.89619,"twenty":-18.648178,"median":-14.436255,"eighty":-10.550062,"marketCap":1129858013},{"date":"2022-06-24","current":-2.2903,"twenty":-18.647542,"median":-14.38433,"eighty":-10.458015,"marketCap":1364691247},{"date":"2022-07-01","current":-2.45885,"twenty":-18.64076,"median":-14.342591,"eighty":-10.337365,"marketCap":1465123071},{"date":"2022-07-08","current":-2.498509,"twenty":-18.63798,"median":-14.300413,"eighty":-10.289314,"marketCap":1488754088},{"date":"2022-07-15","current":-2.228333,"twenty":-18.62081,"median":-14.263271,"eighty":-10.199154,"marketCap":1327767783},{"date":"2022-07-22","current":-2.51586,"twenty":-18.605956,"median":-14.240772,"eighty":-10.029272,"marketCap":1499092658},{"date":"2022-07-29","current":-2.146537,"twenty":-18.593131,"median":-14.233652,"eighty":-9.951747,"marketCap":1279028810},{"date":"2022-08-05","current":-3.256753,"twenty":-18.574173,"median":-14.215884,"eighty":-9.132314,"marketCap":1658876197},{"date":"2022-08-12","current":-3.37608,"twenty":-18.553052,"median":-14.192196,"eighty":-4.665338,"marketCap":1719657184},{"date":"2022-08-19","current":-3.018099,"twenty":-18.523053,"median":-14.156478,"eighty":-4.072548,"marketCap":1537314224},{"date":"2022-08-26","current":-3.050114,"twenty":-18.46994,"median":-14.139769,"eighty":-3.904828,"marketCap":1553621318},{"date":"2022-09-02","current":-2.927877,"twenty":-18.431947,"median":-14.10667,"eighty":-3.545195,"marketCap":1491357868},{"date":"2022-09-09","current":-3.437199,"twenty":-18.422496,"median":-14.103623,"eighty":-3.451169,"marketCap":1750788909},{"date":"2022-09-16","current":-3.242201,"twenty":-18.414899,"median":-14.058044,"eighty":-3.370841,"marketCap":1651463882},{"date":"2022-09-23","current":-2.837654,"twenty":-18.402567,"median":-14.038583,"eighty":-3.306813,"marketCap":1445401512},{"date":"2022-09-30","current":-2.892952,"twenty":-18.38545,"median":-14.012905,"eighty":-3.236962,"marketCap":1473568311},{"date":"2022-10-07","current":-3.029741,"twenty":-18.366723,"median":-13.991375,"eighty":-3.229951,"marketCap":1543244076},{"date":"2022-10-14","current":-2.875489,"twenty":-18.362255,"median":-13.96778,"eighty":-3.214621,"marketCap":1464673532},{"date":"2022-10-21","current":-3.035562,"twenty":-18.359679,"median":-13.921816,"eighty":-3.17166,"marketCap":1546209002},{"date":"2022-10-28","current":-3.198545,"twenty":-18.35685,"median":-13.870509,"eighty":-3.161292,"marketCap":1629226935},{"date":"2022-11-04","current":-2.997162,"twenty":-18.345813,"median":-13.836853,"eighty":-3.129996,"marketCap":1470914038},{"date":"2022-11-11","current":-3.460138,"twenty":-18.3246,"median":-13.814206,"eighty":-3.104263,"marketCap":1698128402},{"date":"2022-11-18","current":-2.896647,"twenty":-18.312845,"median":-13.791224,"eighty":-3.093188,"marketCap":1421584604},{"date":"2022-11-25","current":-2.613379,"twenty":-18.311096,"median":-13.768935,"eighty":-3.082711,"marketCap":1282565289},{"date":"2022-12-02","current":-2.884464,"twenty":-18.306286,"median":-13.735517,"eighty":-3.057099,"marketCap":1415605278},{"date":"2022-12-09","current":-2.707802,"twenty":-18.292985,"median":-13.698738,"eighty":-3.038472,"marketCap":1328905061},{"date":"2022-12-16","current":-2.8205,"twenty":-18.2616,"median":-13.655724,"eighty":-3.022756,"marketCap":1384213820},{"date":"2022-12-23","current":-2.400166,"twenty":-18.250269,"median":-13.5957,"eighty":-3.011005,"marketCap":1177927095},{"date":"2022-12-30","current":-2.320973,"twenty":-18.229368,"median":-13.588886,"eighty":-2.983174,"marketCap":1139061481},{"date":"2023-01-06","current":-2.250917,"twenty":-18.22287,"median":-13.583977,"eighty":-2.971485,"marketCap":1104680360},{"date":"2023-01-13","current":-2.665159,"twenty":-18.209456,"median":-13.580361,"eighty":-2.926919,"marketCap":1307977422},{"date":"2023-01-20","current":-2.56769,"twenty":-18.202214,"median":-13.535005,"eighty":-2.907613,"marketCap":1260142819},{"date":"2023-01-27","current":-2.774811,"twenty":-18.189656,"median":-13.527444,"eighty":-2.896333,"marketCap":1361791350},{"date":"2023-02-03","current":-3.307843,"twenty":-18.183035,"median":-13.492717,"eighty":-2.894698,"marketCap":1623386835},{"date":"2023-02-10","current":-3.475367,"twenty":-18.156973,"median":-13.446485,"eighty":-2.896333,"marketCap":1705602558},{"date":"2023-02-17","current":-3.990124,"twenty":-18.132745,"median":-13.344804,"eighty":-2.896768,"marketCap":1958229055},{"date":"2023-02-24","current":-3.664917,"twenty":-18.127003,"median":-13.338568,"eighty":-2.899947,"marketCap":1763495962},{"date":"2023-03-03","current":-3.419541,"twenty":-18.104572,"median":-13.30953,"eighty":-2.90507,"marketCap":1645424988},{"date":"2023-03-10","current":-4.680888,"twenty":-18.07051,"median":-13.262445,"eighty":-2.907003,"marketCap":2252363830},{"date":"2023-03-17","current":-4.511098,"twenty":-18.064775,"median":-13.248215,"eighty":-2.909464,"marketCap":2170663577},{"date":"2023-03-24","current":-4.960543,"twenty":-18.058861,"median":-13.222467,"eighty":-2.915484,"marketCap":2386928952},{"date":"2023-03-31","current":-5.519853,"twenty":-18.051659,"median":-13.20999,"eighty":-2.925004,"marketCap":2656059196},{"date":"2023-04-06","current":-5.170284,"twenty":-18.049204,"median":-13.190521,"eighty":-2.92955,"marketCap":2487852794},{"date":"2023-04-14","current":-5.213564,"twenty":-18.039702,"median":-13.163935,"eighty":-2.936853,"marketCap":2508678348},{"date":"2023-04-21","current":-5.483231,"twenty":-18.008528,"median":-13.120004,"eighty":-2.945156,"marketCap":2638437573},{"date":"2023-04-28","current":-4.724168,"twenty":-17.996964,"median":-13.108081,"eighty":-2.969338,"marketCap":2273189385},{"date":"2023-05-05","current":-5.098963,"twenty":-17.978328,"median":-13.012532,"eighty":-2.972649,"marketCap":2166763486},{"date":"2023-05-12","current":-5.386016,"twenty":-17.960738,"median":-12.990726,"eighty":-2.974722,"marketCap":2288744245},{"date":"2023-05-19","current":-5.280259,"twenty":-17.943362,"median":-12.958206,"eighty":-2.976725,"marketCap":2243803966},{"date":"2023-05-26","current":-5.114071,"twenty":-17.928317,"median":-12.881958,"eighty":-2.980846,"marketCap":2173183526},{"date":"2023-06-02","current":-5.287813,"twenty":-17.89831,"median":-12.877744,"eighty":-2.983174,"marketCap":2247013986},{"date":"2023-06-09","current":-6.152749,"twenty":-17.895624,"median":-12.814449,"eighty":-2.997162,"marketCap":2614561273},{"date":"2023-06-16","current":-5.861919,"twenty":-17.88701,"median":-12.790369,"eighty":-3.003253,"marketCap":2490975504},{"date":"2023-06-23","current":-6.096093,"twenty":-17.84216,"median":-12.751575,"eighty":-3.008145,"marketCap":2590486123},{"date":"2023-06-30","current":-6.417139,"twenty":-17.809393,"median":-12.697254,"eighty":-3.014278,"marketCap":2726911973},{"date":"2023-07-07","current":-6.420916,"twenty":-17.792412,"median":-12.674549,"eighty":-3.01777,"marketCap":2728516983},{"date":"2023-07-14","current":-6.538004,"twenty":-17.787704,"median":-12.666883,"eighty":-3.018099,"marketCap":2778272292},{"date":"2023-07-21","current":-13.026906,"twenty":-17.752068,"median":-12.666883,"eighty":-3.019263,"marketCap":5535679455},{"date":"2023-07-28","current":-12.206209,"twenty":-17.694646,"median":-12.643182,"eighty":-3.024502,"marketCap":5186930808},{"date":"2023-08-04","current":-9.04402,"twenty":-17.681297,"median":-12.643228,"eighty":-3.032069,"marketCap":5182087735},{"date":"2023-08-11","current":-9.184326,"twenty":-17.667007,"median":-12.605139,"eighty":-3.035562,"marketCap":5262481003},{"date":"2023-08-18","current":-8.05578,"twenty":-17.651492,"median":-12.55478,"eighty":-3.036726,"marketCap":4615840855},{"date":"2023-08-25","current":-7.962207,"twenty":-17.643055,"median":-12.488397,"eighty":-3.038472,"marketCap":4562224963},{"date":"2023-09-01","current":-8.481111,"twenty":-17.638866,"median":-12.434869,"eighty":-3.042698,"marketCap":4859549454},{"date":"2023-09-08","current":-8.174872,"twenty":-17.633393,"median":-12.401532,"eighty":-3.049253,"marketCap":4684079263},{"date":"2023-09-15","current":-8.39888,"twenty":-17.624096,"median":-12.352952,"eighty":-3.051278,"marketCap":4812432458},{"date":"2023-09-22","current":-7.647461,"twenty":-17.620403,"median":-12.30172,"eighty":-3.057099,"marketCap":4381880601},{"date":"2023-09-29","current":-7.69283,"twenty":-17.613798,"median":-12.259147,"eighty":-3.061756,"marketCap":4407876184},{"date":"2023-10-06","current":-6.989615,"twenty":-17.611279,"median":-12.206209,"eighty":-3.063502,"marketCap":4004944635},{"date":"2023-10-13","current":-7.003793,"twenty":-17.6066,"median":-12.141084,"eighty":-3.072815,"marketCap":4013068255},{"date":"2023-10-20","current":-6.998122,"twenty":-17.588228,"median":-12.101539,"eighty":-3.082711,"marketCap":4009818807},{"date":"2023-10-27","current":-7.108708,"twenty":-17.566788,"median":-12.084826,"eighty":-3.083875,"marketCap":4073183042},{"date":"2023-11-03","current":-7.651953,"twenty":-17.537273,"median":-12.012885,"eighty":-3.085039,"marketCap":4687931013},{"date":"2023-11-10","current":-7.686814,"twenty":-17.526243,"median":-11.956547,"eighty":-3.088532,"marketCap":4709288097},{"date":"2023-11-17","current":-8.195103,"twenty":-17.510361,"median":-11.930684,"eighty":-3.094353,"marketCap":5020689120},{"date":"2023-11-24","current":-8.399555,"twenty":-17.494299,"median":-11.913139,"eighty":-3.097079,"marketCap":5145945398},{"date":"2023-12-01","current":-8.152509,"twenty":-17.469189,"median":-11.857337,"eighty":-3.104263,"marketCap":4994594062},{"date":"2023-12-08","current":-9.543916,"twenty":-17.429259,"median":-11.793812,"eighty":-3.115307,"marketCap":5847032617},{"date":"2023-12-15","current":-10.197026,"twenty":-17.381695,"median":-11.731234,"eighty":-3.121801,"marketCap":6247156837},{"date":"2023-12-22","current":-11.014832,"twenty":-17.355217,"median":-11.719248,"eighty":-3.129996,"marketCap":6748181947},{"date":"2023-12-29","current":-11.872393,"twenty":-17.354261,"median":-11.72602,"eighty":-3.131606,"marketCap":7273562444},{"date":"2024-01-05","current":-10.483826,"twenty":-17.341436,"median":-11.702268,"eighty":-3.143193,"marketCap":6422863559},{"date":"2024-01-12","current":-11.136935,"twenty":-17.32979,"median":-11.659423,"eighty":-3.152765,"marketCap":6822987779},{"date":"2024-01-19","current":-10.665561,"twenty":-17.326345,"median":-11.629086,"eighty":-3.155517,"marketCap":6534202473},{"date":"2024-01-26","current":-10.242459,"twenty":-17.321786,"median":-11.592759,"eighty":-3.161292,"marketCap":6274991565},{"date":"2024-02-02","current":-9.458728,"twenty":-17.298763,"median":-11.572263,"eighty":-3.166531,"marketCap":5794842502},{"date":"2024-02-09","current":-9.359342,"twenty":-17.266338,"median":-11.503758,"eighty":-3.167695,"marketCap":5733954033},{"date":"2024-02-16","current":-11.139775,"twenty":-17.227747,"median":-11.486207,"eighty":-3.17166,"marketCap":6824727449},{"date":"2024-02-23","current":-9.087803,"twenty":-17.158784,"median":-11.419175,"eighty":-3.176583,"marketCap":5845292947},{"date":"2024-03-01","current":-9.335554,"twenty":-17.077932,"median":-11.339868,"eighty":-3.183466,"marketCap":6004646954},{"date":"2024-03-08","current":-8.603155,"twenty":-17.056112,"median":-11.314907,"eighty":-3.185768,"marketCap":5533566780},{"date":"2024-03-15","current":-7.84321,"twenty":-17.050104,"median":-11.228386,"eighty":-3.189231,"marketCap":5044768381},{"date":"2024-03-22","current":-8.310648,"twenty":-17.043563,"median":-11.170649,"eighty":-3.201455,"marketCap":5345425509},{"date":"2024-03-28","current":-8.849779,"twenty":-17.040033,"median":-11.139775,"eighty":-3.213097,"marketCap":5692195694},{"date":"2024-04-05","current":-8.072628,"twenty":-17.037162,"median":-11.11833,"eighty":-3.216906,"marketCap":5192330161},{"date":"2024-04-12","current":-8.13285,"twenty":-16.996966,"median":-11.074422,"eighty":-3.224739,"marketCap":5231065129},{"date":"2024-04-19","current":-7.154958,"twenty":-16.991224,"median":-11.019807,"eighty":-3.227649,"marketCap":4602083038},{"date":"2024-04-26","current":-7.078422,"twenty":-16.989711,"median":-11.000634,"eighty":-3.233403,"marketCap":4552854895},{"date":"2024-05-03","current":-9.643939,"twenty":-16.978764,"median":-10.972094,"eighty":-3.23347,"marketCap":5190965672},{"date":"2024-05-10","current":-9.988117,"twenty":-16.973335,"median":-10.959651,"eighty":-3.242201,"marketCap":5376223639},{"date":"2024-05-17","current":-10.791199,"twenty":-16.9694,"median":-10.928667,"eighty":-3.256753,"marketCap":5808492230},{"date":"2024-05-24","current":-9.650892,"twenty":-16.924463,"median":-10.876468,"eighty":-3.271292,"marketCap":5194708257},{"date":"2024-05-31","current":-10.029835,"twenty":-16.892887,"median":-10.864916,"eighty":-3.280616,"marketCap":5398679151},{"date":"2024-06-07","current":-9.428393,"twenty":-16.866618,"median":-10.810296,"eighty":-3.285276,"marketCap":5074945531},{"date":"2024-06-14","current":-10.081983,"twenty":-16.844797,"median":-10.786611,"eighty":-3.287604,"marketCap":5426748540},{"date":"2024-06-21","current":-9.404057,"twenty":-16.814328,"median":-10.746489,"eighty":-3.296398,"marketCap":5061846483},{"date":"2024-06-28","current":-8.760896,"twenty":-16.75053,"median":-10.728734,"eighty":-3.300213,"marketCap":4715657352},{"date":"2024-07-05","current":-8.691365,"twenty":-16.630613,"median":-10.662018,"eighty":-3.300213,"marketCap":4678231500},{"date":"2024-07-12","current":-9.348432,"twenty":-16.450307,"median":-10.55255,"eighty":-3.300213,"marketCap":5031905801},{"date":"2024-07-15","current":-9.428393,"twenty":-16.387081,"median":-10.550062,"eighty":-3.300213,"marketCap":5074945531},{"date":"2024-08-02","current":-10.84727,"twenty":-15.904573,"median":-10.459746,"eighty":-3.282947,"marketCap":4922697080},{"date":"2024-08-09","current":-10.142902,"twenty":-15.794001,"median":-10.436937,"eighty":-3.282947,"marketCap":4603041426},{"date":"2024-08-16","current":-10.341782,"twenty":-15.720083,"median":-10.324027,"eighty":-3.282947,"marketCap":4693297140},{"date":"2024-08-23","current":-10.312779,"twenty":-15.554297,"median":-10.305383,"eighty":-3.282947,"marketCap":4680134848},{"date":"2024-08-30","current":-10.200908,"twenty":-15.468081,"median":-10.298317,"eighty":-3.282947,"marketCap":4629366009},{"date":"2024-09-06","current":-12.968661,"twenty":-15.406372,"median":-10.298317,"eighty":-3.282947,"marketCap":5885424699},{"date":"2024-09-13","current":-11.166307,"twenty":-15.373674,"median":-10.298317,"eighty":-3.282947,"marketCap":5067482289},{"date":"2024-09-20","current":-11.116587,"twenty":-15.373674,"median":-10.298317,"eighty":-3.282947,"marketCap":5044918360},{"date":"2024-09-27","current":-10.142902,"twenty":-15.346079,"median":-10.291437,"eighty":-3.282947,"marketCap":4603041426},{"date":"2024-10-04","current":-10.619386,"twenty":-15.346079,"median":-10.287903,"eighty":-3.282947,"marketCap":4819279074},{"date":"2024-10-11","current":-10.341782,"twenty":-15.346079,"median":-10.269126,"eighty":-3.282947,"marketCap":4693297140},{"date":"2024-10-18","current":-10.851413,"twenty":-15.346079,"median":-10.269126,"eighty":-3.282947,"marketCap":4924577408},{"date":"2024-10-25","current":-10.014458,"twenty":-15.346079,"median":-10.247312,"eighty":-3.282947,"marketCap":4544751277},{"date":"2024-10-31","current":-9.857011,"twenty":-15.346079,"median":-10.213164,"eighty":-3.282947,"marketCap":4473298837},{"date":"2024-11-08","current":-10.722969,"twenty":-15.348937,"median":-10.208384,"eighty":-3.280616,"marketCap":4866287259},{"date":"2024-11-15","current":-10.382683,"twenty":-15.348937,"median":-10.208384,"eighty":-3.280616,"marketCap":4556544126},{"date":"2024-11-22","current":-10.008028,"twenty":-15.271599,"median":-10.197026,"eighty":-3.280616,"marketCap":4392122998},{"date":"2024-11-29","current":-11.665984,"twenty":-15.218244,"median":-10.186868,"eighty":-3.280616,"marketCap":5119733736},{"date":"2024-12-06","current":-11.48081,"twenty":-15.156078,"median":-10.186868,"eighty":-3.280616,"marketCap":5038468121},{"date":"2024-12-13","current":-11.915754,"twenty":-15.091844,"median":-10.186868,"eighty":-3.280616,"marketCap":5229347821},{"date":"2024-12-20","current":-11.287023,"twenty":-14.973758,"median":-10.186868,"eighty":-3.280616,"marketCap":4953422710},{"date":"2024-12-27","current":-12.225813,"twenty":-14.909796,"median":-10.186868,"eighty":-3.280616,"marketCap":5365420478},{"date":"2025-01-03","current":-12.143992,"twenty":-14.881378,"median":-10.186868,"eighty":-3.280616,"marketCap":5329512416},{"date":"2025-01-10","current":-12.68229,"twenty":-14.811419,"median":-10.183098,"eighty":-3.278285,"marketCap":5565749668},{"date":"2025-01-17","current":-14.689063,"twenty":-14.775692,"median":-10.183098,"eighty":-3.278285,"marketCap":6446442146},{"date":"2025-01-24","current":-15.972364,"twenty":-14.759516,"median":-10.183098,"eighty":-3.278285,"marketCap":7009631756},{"date":"2025-01-31","current":-15.49005,"twenty":-14.759516,"median":-10.183098,"eighty":-3.278285,"marketCap":6797963177},{"date":"2025-02-07","current":-14.081863,"twenty":-14.698128,"median":-10.183098,"eighty":-3.278285,"marketCap":6179966525},{"date":"2025-02-14","current":-13.590936,"twenty":-14.67161,"median":-10.183098,"eighty":-3.278285,"marketCap":5964518151},{"date":"2025-02-21","current":-12.982947,"twenty":-14.658475,"median":-10.183098,"eighty":-3.278285,"marketCap":6955769662},{"date":"2025-02-28","current":-12.15831,"twenty":-14.555662,"median":-10.183098,"eighty":-3.278285,"marketCap":6513960440},{"date":"2025-03-07","current":-11.441236,"twenty":-14.509608,"median":-10.179327,"eighty":-3.275954,"marketCap":6129779415},{"date":"2025-03-14","current":-11.469635,"twenty":-14.509608,"median":-10.186868,"eighty":-3.275954,"marketCap":6144994506},{"date":"2025-03-21","current":-12.037614,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6449296307},{"date":"2025-03-28","current":-12.921532,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6922865986},{"date":"2025-04-04","current":-12.094412,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6479726487},{"date":"2025-04-11","current":-11.469635,"twenty":-14.509348,"median":-10.207864,"eighty":-3.278285,"marketCap":6144994506},{"date":"2025-04-17","current":-12.016315,"twenty":-14.509348,"median":-10.207864,"eighty":-3.278285,"marketCap":6437884990},{"date":"2025-04-25","current":-12.765338,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6839182990},{"date":"2025-05-02","current":-10.915822,"twenty":-14.487131,"median":-10.207344,"eighty":-3.275954,"marketCap":7291419648},{"date":"2025-05-09","current":-9.906677,"twenty":-14.440661,"median":-10.200908,"eighty":-3.275954,"marketCap":6617343092},{"date":"2025-05-16","current":-9.591141,"twenty":-14.390691,"median":-10.17585,"eighty":-3.275954,"marketCap":6406575492},{"date":"2025-05-23","current":-9.372256,"twenty":-14.253095,"median":-10.142902,"eighty":-3.275954,"marketCap":6260367338},{"date":"2025-05-30","current":-9.485963,"twenty":-14.231346,"median":-10.123196,"eighty":-3.275954,"marketCap":6336319626},{"date":"2025-06-06","current":-10.898766,"twenty":-14.231346,"median":-10.116749,"eighty":-3.275954,"marketCap":7280026804},{"date":"2025-06-13","current":-11.271155,"twenty":-14.231346,"median":-10.116749,"eighty":-3.275954,"marketCap":7528770548},{"date":"2025-06-20","current":-11.370648,"twenty":-14.232499,"median":-10.113252,"eighty":-3.273623,"marketCap":7595228800},{"date":"2025-06-27","current":-12.826091,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8567418086},{"date":"2025-07-03","current":-12.50487,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8352852872},{"date":"2025-07-11","current":-13.152997,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8785780914},{"date":"2025-07-18","current":-13.286602,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8875024852},{"date":"2025-07-25","current":-12.979594,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8669953675},{"date":"2025-08-01","current":-13.437263,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8975661634},{"date":"2025-08-08","current":-11.313785,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8784192758},{"date":"2025-08-15","current":-12.601513,"twenty":-14.224806,"median":-10.122691,"eighty":-3.273623,"marketCap":9784004034},{"date":"2025-08-22","current":-12.367605,"twenty":-14.224806,"median":-10.1284,"eighty":-3.273623,"marketCap":9602393955},{"date":"2025-08-29","current":-12.943758,"twenty":-14.224806,"median":-10.1284,"eighty":-3.273623,"marketCap":10049728255},{"date":"2025-09-05","current":-12.761556,"twenty":-14.227887,"median":-10.142902,"eighty":-3.271292,"marketCap":9908263562},{"date":"2025-09-12","current":-12.951145,"twenty":-14.224806,"median":-10.142902,"eighty":-3.273623,"marketCap":10055463310},{"date":"2025-09-19","current":-13.130885,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":10195016318},{"date":"2025-09-26","current":-12.064755,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":9367256696},{"date":"2025-10-03","current":-13.118574,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":10185457893},{"date":"2025-10-10","current":-13.490366,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"marketCap":10474122334},{"date":"2025-10-14","current":-13.778443,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"marketCap":10697789483}],"updateTime":1760566498328},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBIO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566986310","title":"Jefferies Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2566986310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566986310?lang=en_us&edition=fundamental","pubTime":"2025-09-11 01:15","pubTimestamp":1757524514,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai reiterated a Buy rating on BridgeBio Pharma today and set a price target of $70.00. The company’s shares opened today...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-bridgebio-pharma-bbio-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-bridgebio-pharma-bbio-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBIO"],"gpt_icon":0},{"id":"2566304556","title":"Frank McCormick, Director, Reports Disposal of Common Shares of BridgeBio Pharma Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2566304556","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566304556?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:07","pubTimestamp":1757369221,"startTime":"0","endTime":"0","summary":"Frank McCormick, a Director at BridgeBio Pharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL7qJmHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4139","BK4588","BBIO"],"gpt_icon":0},{"id":"2565454365","title":"BridgeBio Pharma Inc. Publishes Document on Infigratinib's Preclinical Improvement in Crouzon/Pfeiffer Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2565454365","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565454365?lang=en_us&edition=fundamental","pubTime":"2025-09-07 05:00","pubTimestamp":1757192453,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. published a document detailing the preclinical improvement of skull measures using infigratinib in a mouse model of Crouzon/Pfeiffer syndromes. The study involved various experimental groups and demonstrated a dose-dependent response with infigratinib, showing improvement in skull length, height, nasal bone length, and jaw dimensions in the treated mice. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief on September 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250906:nNDL3RhSSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BBIO","BK4139","BK4588","BK4505"],"gpt_icon":0},{"id":"2565106755","title":"BRIEF-Bridgebio Pharma Says Intends To Initiate Registrational Clinical Study Of Encaleret In 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2565106755","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565106755?lang=en_us&edition=fundamental","pubTime":"2025-09-07 02:32","pubTimestamp":1757183541,"startTime":"0","endTime":"0","summary":"BRIEF-Bridgebio Pharma Says Intends To Initiate Registrational Clinical Study Of Encaleret In 2026Sept 6 (Reuters) - BridgeBio Pharma Inc BBIO.O:BRIDGEBIO PHARMA - INTENDS TO INITIATE REGISTRATIONAL C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250906:nFWN3US110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4588","BK4505","BK4139","BK4585"],"gpt_icon":0},{"id":"2565510678","title":"BridgeBio Pharma - Intends to Initiate Registrational Clinical Study of Encaleret in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2565510678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565510678?lang=en_us&edition=fundamental","pubTime":"2025-09-07 02:31","pubTimestamp":1757183492,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250906:nFWN3US110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4588","BK4505","BBIO"],"gpt_icon":0},{"id":"2565510673","title":"BridgeBio Pharma Inc - Phase 2 Study Evaluated Encaleret's Effects on Calcium Handling","url":"https://stock-news.laohu8.com/highlight/detail?id=2565510673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565510673?lang=en_us&edition=fundamental","pubTime":"2025-09-07 02:31","pubTimestamp":1757183492,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250906:nFWN3US110:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BBIO","BK4505","BK4585","BK4588"],"gpt_icon":0},{"id":"2565106205","title":"BridgeBio Pharma Inc  - Encaleret Was Well-Tolerated With No Serious Adverse Events Reported Over Study Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2565106205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565106205?lang=en_us&edition=fundamental","pubTime":"2025-09-07 02:31","pubTimestamp":1757183492,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250906:nFWN3US110:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BBIO","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2564306582","title":"BUZZ-U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2564306582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564306582?lang=en_us&edition=fundamental","pubTime":"2025-09-04 23:54","pubTimestamp":1757001252,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Gap, Aquestive Therapeutics, LumentumEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nL6N3UR0RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETR","CNF","SCVL","DOLE","AEO","RCKT","TTC","LITB","NEM","CAL","CUBI","NEON","SCCO","BRKR","CRMT","CIGL","HPE","ICLR","JEM","FANG","DAVA","DLO","AQST","DYN","NI","BHP.AU","DLTH","TORO","CTRI","ARTL","PI","WDC","AU","LDOS","SRPT","WLY","CIEN","CNC","FCX","GAP","TROW","LITE","BBIO","AGIO","PD"],"gpt_icon":1},{"id":"2564379751","title":"BUZZ-US FDA program favorable for rare disease drug developers, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2564379751","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564379751?lang=en_us&edition=fundamental","pubTime":"2025-09-04 19:39","pubTimestamp":1756985950,"startTime":"0","endTime":"0","summary":"BUZZ-US FDA program favorable for rare disease drug developers, says Jefferies** Brokerage Jefferies says a new program that aims to expedite approvals for rare disease treatments should bode well for drug developers in this space** Earlier this week, the U.S. FDA proposed a new process to streamline the approval of drugs targeting rare diseases with very small patient populations, including cases supported by data from single-arm clinical trials** The brokerage says the decision could provide some upside if the FDA shows flexibility in its eligibility threshold of fewer than 1,000 patients affected by the disease** Jefferies says companies like BridgeBio Pharma BBIO.O, Sarepta Therapeutics SRPT.O, Dyne Therapeutics DYN.O and Rocket Pharmaceuticals RCKT.O could be \"more emboldened\" to pursue treatments for diseases with smaller patient population that show a valid mechanism of action ** Up to last close, RCKT down 73.6%, DYN down 42.7% and SRPT down 84.4% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nL4N3UR0RR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","BBIO","BK4505","IE0009355771.USD","RCKT","BK4588","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","SRPT","IE00BFTCPJ56.SGD","DYN","BK4139","IE0002141913.USD"],"gpt_icon":0},{"id":"2564392859","title":"BridgeBio Pharma Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2564392859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564392859?lang=en_us&edition=fundamental","pubTime":"2025-09-03 22:52","pubTimestamp":1756911120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 03, 2025 10:52 ET (14:52 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO"],"gpt_icon":0},{"id":"2564602463","title":"BridgeBio Pharma to Host Investor Webinar on Phase 3 Trial for Encaleret in Treating Autosomal Dominant Hypocalcemia Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2564602463","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564602463?lang=en_us&edition=fundamental","pubTime":"2025-09-03 19:31","pubTimestamp":1756899060,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. has announced an upcoming investor webinar scheduled for September 10, 2025, focusing on their ongoing clinical development program for autosomal dominant hypocalcemia type 1 . The webinar will feature Rachel Gafni, M.D., a Senior Research Physician at the National Institute of Dental and Craniofacial Research and Principal Investigator for the CALIBRATE Phase 3 clinical trial. Dr. Gafni will provide insights into the pathophysiology of ADH1, the current unmet medical needs, and the rationale for investigating encaleret as a potential treatment. Executive members of the ADH1 program team will discuss the ongoing clinical development and the Phase 3 CALIBRATE study, with topline results anticipated in fall 2025. The live webcast can be accessed through the BridgeBio website, and a replay will be available for 30 days following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDL1fXTQr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210150020.SGD","BK4505","IE00B64PRP62.GBP","BBIO","IE00BKPKM429.USD","BK4588","BK4139","BK4112","LU2095319765.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ","LU0314104364.USD"],"gpt_icon":0},{"id":"2564367404","title":"BridgeBio Pharma Price Target Maintained With a $70.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2564367404","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564367404?lang=en_us&edition=fundamental","pubTime":"2025-09-03 19:01","pubTimestamp":1756897260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 03, 2025 07:01 ET (11:01 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO"],"gpt_icon":0},{"id":"2564363360","title":"U.S. RESEARCH ROUNDUP-BOK Financial, Sable Offshore, Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2564363360","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564363360?lang=en_us&edition=fundamental","pubTime":"2025-09-03 16:00","pubTimestamp":1756886444,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-BOK Financial, Sable Offshore, ZscalerSept 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BOK F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nL8N3UQ096:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFWM","PNFP","EWBC","KEY","HQY","SOC","CFR","COLB","FITB","AUB","WTFC","CATY","BAC","EGBN","BBIO","TECH","FCNCA","IONS","FIZN","FHN","CFG","ZS","WBS","BKU","VLY","MLYS","SNV","TCBI","FLR","PRAX","PB","BOKF","RF","SSB","STZ","ZION","KHC","BANC","BRZE","CMA","HBAN","INSM","WAL","AX","FLG","ONB","MTB"],"gpt_icon":1},{"id":"2564801581","title":"BridgeBio Pharma to Present Promising Phase 2 Data for Encaleret in Treating Post-Surgical Hypoparathyroidism at ASBMR Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2564801581","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564801581?lang=en_us&edition=fundamental","pubTime":"2025-09-02 19:30","pubTimestamp":1756812641,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma to Present Promising Phase 2 Data for Encaleret in Treating Post-Surgical Hypoparathyroidism at ASBMR Annual Meeting 2025. BridgeBio Pharma Inc. has announced that it will present Phase 2 proof-of-concept data for the drug Encaleret in treating post-surgical hypoparathyroidism at the upcoming American Society for Bone and Mineral Research  Annual Meeting 2025. The presentation, led by Dr. Iris Hartley from the National Institute of Dental and Craniofacial Research, is scheduled for September 6, 2025. In addition, BridgeBio will share findings from two poster sessions on skeletal dysplasia, highlighting the efficacy of Infigratinib in improving bone growth and skull measures in mouse models. These sessions will be presented by Bhavik Shah, Ph.D., Senior Vice President of Research at BridgeBio, on September 5 and 7, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and tim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL8D61ww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","IE00BGHQF748.EUR","NDAQ","BK4585","LU0314104364.USD","LU2095319765.USD","BK4588","IE00BKPKM429.USD","BK4139","BK4505","LU2210149790.SGD"],"gpt_icon":0},{"id":"2563834118","title":"Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (Cvm) Through Month 42 of the Attribute-Cm Open Label Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2563834118","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563834118?lang=en_us&edition=fundamental","pubTime":"2025-08-30 19:15","pubTimestamp":1756552501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250830:nTUA7N0F8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","BK4588","BK4505","BBIO"],"gpt_icon":0},{"id":"2563076264","title":"BridgeBio Pharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2563076264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563076264?lang=en_us&edition=fundamental","pubTime":"2025-08-30 02:31","pubTimestamp":1756492260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 29, 2025 14:31 ET (18:31 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO"],"gpt_icon":0},{"id":"2563021726","title":"BridgeBio Pharma, Inc. : H.c. Wainwright Raises Target Price to $70 From $56","url":"https://stock-news.laohu8.com/highlight/detail?id=2563021726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563021726?lang=en_us&edition=fundamental","pubTime":"2025-08-29 22:10","pubTimestamp":1756476639,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nAZN4FWP13:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","BK4585","BBIO","BK4588"],"gpt_icon":0},{"id":"2563109026","title":"BridgeBio Pharma Inc. Releases Document on Acoramidis for Transthyretin Amyloid Cardiomyopathy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2563109026","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563109026?lang=en_us&edition=fundamental","pubTime":"2025-08-29 21:18","pubTimestamp":1756473504,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. has published a document focusing on the treatment of transthyretin amyloid cardiomyopathy  using Acoramidis, an oral TTR stabilizer. The document discusses the progressive nature of ATTR-CM, characterized by the destabilization of transthyretin leading to amyloid fibril aggregation in the heart, and highlights the role of Acoramidis in achieving near-complete TTR stabilization for adult patients with wild-type or variant ATTR-CM. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL26Yn16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4588","BK4139","BBIO","BK4585"],"gpt_icon":0},{"id":"2562474365","title":"BridgeBio Pharma Inc. to Participate in Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2562474365","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562474365?lang=en_us&edition=fundamental","pubTime":"2025-08-27 19:35","pubTimestamp":1756294503,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc., a biopharmaceutical company focused on genetic diseases, will participate in the Morgan Stanley Global Healthcare Conference in New York, NY. The company is scheduled to host a fireside chat on Monday, September 8, at 3:20 pm ET. The live webcast of BridgeBio's presentation will be accessible on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on August 27, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDLHZpDv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU2089283258.USD","LU2095319765.USD","BK4505","LU1989772840.SGD","LU2271345857.HKD","LU0795875086.SGD","LU2210150020.SGD","LU2347655156.SGD","LU1162221912.USD","NDAQ","LU2210149790.SGD","BK4534","IE00BGHQF748.EUR","LU0882574139.USD","LU1074936037.SGD","IE00BKVL7J92.USD","LU0158827781.USD","LU1363072403.SGD","LU1244550221.USD","LU1732800096.USD","IE00BKPKM429.USD","LU1548497426.USD","LU0106831901.USD","LU1732799900.SGD","BK4112","BK4581","LU0314104364.USD","LU1989772923.USD","LU0267386448.USD","LU0098860793.USD","BBIO","IE00BZ1G4Q59.USD","BK4127","LU0795875169.SGD","LU1244550494.USD","LU0971096721.USD","BK4585","BK4516","BK4139","IE00B64PRP62.GBP","LU0006306889.USD","LU2089284900.SGD","BK4588","BK4504","LU1244550577.SGD","LU1720051017.SGD","LU0225283273.USD","LU1720051108.HKD","LU0320765646.SGD"],"gpt_icon":0},{"id":"2562463212","title":"BridgeBio Pharma to Present New Findings from ATTRibute-CM Study on Acoramidis at ESC Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2562463212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562463212?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:30","pubTimestamp":1756121417,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc., a biopharmaceutical company specializing in genetic diseases, has announced plans to present additional data from its ATTRibute-CM study at the upcoming European Society of Cardiology  Congress 2025 in Madrid, Spain. The presentation will include new findings from the open-label extension of the ATTRibute-CM trial, focusing on the impact of acoramidis on cardiovascular mortality at Month 42. The data will be delivered through a rapid-fire oral presentation by Dr. Kevin Alexander from Stanford University School of Medicine on August 30. Additionally, two ePosters detailing the Month 30 results of the acoramidis trial, including improvements in NT-proBNP levels and changes in NAC ATTR Stage, will also be presented by Dr. Nitasha Sarswat of UChicago Medicine and Dr. Julian Gillmore of University College London's Centre for Amyloidosis. These presentations aim to provide further insights into the efficacy and safety of acoramidis in treating transthyretin-mediated am","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL1YlfVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","BK4505","NDAQ","BK4585","BBIO","LU2095319765.USD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":111,"code":"91000000","status":"200"}]}}